Skip to main content
logo
Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
225.60
-5.10 (-2.21%)
Sep 25, 2026, 4:00 PM EDT - Market closed

Ascendis Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Debt / Equity Ratio
0.31-5.35-8.10-4.421.930.12
Debt / FCF Ratio
1.3419.20----
Net Debt / Equity Ratio
-0.25-1.57-2.81-1.68-0.89-0.77
Net Debt / EBITDA Ratio
-1.37-1.95-1.08-0.560.431.57
Net Debt / FCF Ratio
-1.085.63-0.97-0.520.461.55
Asset Turnover
0.620.580.360.280.050.01
Inventory Turnover
0.300.320.180.260.12-
Quick Ratio
2.230.720.810.621.067.03
Current Ratio
2.991.041.170.951.298.03
Return on Equity (ROE)
118.78%---818.43%-101.69%-44.54%
Return on Assets (ROA)
9.58%-6.86%-17.38%-29.73%-32.29%-27.35%
Return on Capital Employed (ROCE)
14.20%-58.40%-102.60%-511.40%-150.60%-45.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Buyback Yield / Dilution
-6.52%-4.69%-2.85%-0.38%-2.37%-8.21%
SEC Filings: 10-K · 10-Q